Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MDxHealth SA's Prostate Cancer Test Approved by New York State Department of Health


Wednesday, 10 Jul 2013 02:00am EDT 

MDxHealth SA announced that the New York State Department of Health (NYSDOH) has certified and granted approval for the ConfirmMDx for Prostate Cancer test. This approval by NYSDOH completes MDxHealth SA's list of state licensures, allowing the Company to offer the test in all 50 states. The ConfirmMDx for Prostate Cancer test is performed on tissue obtained from a previous negative prostate biopsy to help distinguish patients who have a true-negative result and may forego an unnecessary repeat biopsy from those at high risk for missed cancer. 

Company Quote

3.99
-0.074 -1.82%
7:24am EDT